| Date | Title | Description |
| 07.09.2025 | Galvanize Therapeutics Secures $100M: Revolutionizing Oncology and Chronic Lung Disease Treatment | Galvanize Therapeutics landed a significant $100 million Series C financing. This substantial capital propels its innovative pulsed electric field (PEF) therapies. The Redwood City firm targets critical unmet needs in oncology and chronic l... |
| 06.09.2025 | Galvanize Therapeutics: $100 Million Raised For Advancing Therapies For Cancer And Chronic Lung Disease | Galvanize Therapeutics, a commercial-stage medical technology company developing novel pulsed electric field therapies, has announced the successful close of a $100 million Series C financing round. The round was oversubscribed, reflecting ... |
| 04.09.2025 | Galvanize Therapeutics nets $100M, and a new CEO, to bring pulsed field ablation to lung cancer | Galvanize Therapeutics has raised $100 million in venture capital backing—and is making a change in leadership—to help energize its development of pulsed field ablation technology for use against cancer and respiratory conditions.
The compa... |
| 03.09.2025 | Galvanize Therapeutics Raises $100M in Series C Financing | Galvanize Therapeutics, Redwood City, CA-based commercial-stage medical technology company advancing pulsed electric field (PEF) therapies for oncology and chronic lung disease, raised a $100m Series C financing.
The round was led by Sofinn... |
| 03.09.2025 | Galvanize Therapeutics Raises $100 Million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease | Sofinnova Partners leads premier investor syndicate backing Galvanize's breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach targeting solid tumors and chronic bronchitis, the leading cause of COPD.
REDWO... |
| 20.05.2025 | New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection | Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures.
REDWOOD CITY, Calif., May 20, 2025 /PRNewswire/ -- A new publication featuring Aliya® PEF has been published in t... |
| 20.05.2025 | New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection | Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures.
REDWOOD CITY, Calif., May 20, 2025 /PRNewswire/ -- A new publication featuring Aliya® PEF has been published in t... |
| 06.08.2024 | Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung | REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed enrollment in the AFFINITY study evaluating Aliya... |
| 06.08.2024 | Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung | REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed enrollment in the AFFINITY study evaluating Aliya... |
| 02.07.2024 | Galvanize Appoints Executive Chairman and New Oncology-Focused Director to the Board of Directors | Doug Godshall Becomes Executive Chairman
Zhen Su, MD, MBA, Appointed to the Board of Directors to Bring Oncology Expertise
REDWOOD CITY, Calif., July 2, 2024 /PRNewswire/ -- Galvanize, a leader in Pulsed Electric Field (PEF) technologies, t... |
| 02.07.2024 | Galvanize Appoints Executive Chairman and New Oncology-Focused Director to the Board of Directors | Doug Godshall Becomes Executive Chairman
Zhen Su, MD, MBA, Appointed to the Board of Directors to Bring Oncology Expertise
REDWOOD CITY, Calif., July 2, 2024 /PRNewswire/ -- Galvanize, a leader in Pulsed Electric Field (PEF) technologies, t... |
| 28.05.2024 | Galvanize Receives FDA Clearance for the INUMI Flex Endoscopic Needle, Expanding its Aliya® Pulsed Electric Field (PEF) Portfolio for Soft Tissue Ablation | First Commercially Available Endoscopic Pulsed Electric Field Ablation System for Soft Tissue Lesions
REDWOOD CITY, Calif., May 28, 2024 /PRNewswire/ -- Galvanize today announced that it received U.S. Food and Drug Administration 510(k) reg... |
| 28.05.2024 | Galvanize Receives FDA Clearance for the INUMI Flex Endoscopic Needle, Expanding its Aliya® Pulsed Electric Field (PEF) Portfolio for Soft Tissue Ablation | First Commercially Available Endoscopic Pulsed Electric Field Ablation System for Soft Tissue Lesions
REDWOOD CITY, Calif., May 28, 2024 /PRNewswire/ -- Galvanize today announced that it received U.S. Food and Drug Administration 510(k) reg... |
| 06.11.2023 | Galvanize Therapeutics Announces Promising Data on the Aliya™ Pulsed Electric Field (PEF) System in Early-Stage Non-Small Cell Lung Cancer | SAN DIEGO, Nov. 6, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies, unveiled compelling data from the INCITE-ES clinical study at the recent Society for Immunotherapy for Cancer (SIT... |
| 20.09.2023 | Galvanize Therapeutics Begins U.S. Clinical Study Using Aliya™ Pulsed Electric Field (PEF) for Stage IV Non-Small Cell Lung Cancer or Metastasis to the Lung | First patient treated in the U.S. with Aliya PEF delivered via an endobronchial approach with robotic-assisted navigation
REDWOOD CITY, Calif. , Sept. 20, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc. today announced the treatment of t... |
| 19.06.2023 | Galvanize Therapeutics Completes Enrollment in Pivotal Trial of RheOx® System for Chronic Bronchitis | REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field (PEF) therapies for COPD, soft tissue, and cardiac arrhythmias, has completed enrollment in the RheSolve pivotal ... |
| 30.05.2023 | Galvanize Announces License Agreement and Partnership with Energenx Medical for its Technologies in China | License will maximize the availability of Pulsed Electric Field therapies for the population
Energenx has obtained Green Channel approval for RheOx, Galvanize's proprietary Pulsed Electric Field (PEF) system for the treatment of Chronic Br... |
| 07.03.2023 | New Interventional Oncology Data Show Potential for Aliya™ Pulsed Electric Field (PEF) System in Treatment of Solid Tumors | Galvanize Therapeutics data presented at SIR 2023 include PEF safety and feasibility results in patients with non-small cell lung cancer, and pre-clinical results comparing PEF and radiofrequency ablation
PHOENIX, March 7, 2023 /PRNewswire... |
| 01.03.2023 | Galvanize Therapeutics Announces First Human Use of QuickShot: A Novel Contact-Sensing, Large Area, Focal Pulsed Electric Field Mapping and Ablation Catheter | REDWOOD CITY, Calif., March 1, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc. today announced the first human investigational use of its large-area, focal, Pulsed Electric Field (PEF) ablation catheter called QuickShot™ in the QuickShot ... |
| 10.11.2022 | Galvanize Therapeutics Presents Clinical Data Using Pulsed Electric Field (PEF) Energy for Non-Small Cell Lung Cancer | INCITE ES clinical study results suggest the Aliya™ PEF system may stimulate an immune response
BOSTON, Nov. 10, 2022 /PRNewswire/ -- Galvanize Therapeutics, Inc., a commercial-stage biomedical platform company operating at the convergence... |
| 20.09.2022 | How 3 companies merged and raised $100M to treat range of diseases by pulsing cells (San Francisco Business Times) | By Ron Leuty
Republished with permission from San Francisco Business Times
Three related companies are coming together as one to develop pulsed electric field therapies — basically using energy to make cells do what doctors want them to d... |
| 15.09.2022 | Galvanize Therapeutics Announces Merger to Create the Premier Pulsed Electric Field Therapy Company and Completion of $100 Million Series B Financing | Merger unites three companies created by life sciences venture capital firm ATP—Gala Therapeutics, Galaxy Medical, and Galvanize Therapeutics—to create a single company based on the AliyaTM Pulsed Electric Field (PEF) energy platform |
| 15.09.2022 | Galvanize Therapeutics Announces Merger to Create the Premier Pulsed Electric Field Therapy Company and Completion of $100 Million Series B Financing | Merger unites three companies created by life sciences venture capital firm ATP—Gala Therapeutics, Galaxy Medical, and Galvanize Therapeutics—to create a single company based on the AliyaTM Pulsed Electric Field (PEF) energy platform
Galva... |
| 15.09.2022 | Galvanize Therapeutics Pulls In $100M Series B |
SAN CARLOS, CA, Galvanize Therapeutics today announced it has completed a $100 million Series B funding round.
>> Click here for more funding data on Galvanize Therapeutics
>> To export Galvanize Therapeutics funding data to... |
| - | Galvanize Therapeutics | “Home | Galvanize” |
| - | Galvanize Therapeutics | “Galvanize” |
